Taiwan ED Airway Quality Surveillance Registry (TEAR)

May 5, 2026 updated by: YANG TING HAO, Chang Gung Memorial Hospital

The Taiwan ED Airway Quality Surveillance Registry (TEAR): A Prospective Multicenter Observational Study

This prospective, multicenter observational registry systematically captures all emergency department tracheal intubations across participating hospitals in Taiwan. The registry focuses on process quality indicators, including first-pass success, and patient-safety outcomes, including hypoxemia, hypotension, and peri-intubation cardiac arrest within 30 minutes of intubation. Routinely generated laboratory and physiologic variables are also collected to improve risk stratification and identify predictors of major adverse events. The study is non-interventional and does not alter clinical care.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

1200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Taiwan
      • New Taipei City, Taiwan
        • New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Consecutive adult emergency department patients undergoing tracheal intubation at participating hospitals in Taiwan.

Description

Inclusion Criteria:

  • Undergoing tracheal intubation in the emergency department during the study period

Exclusion Criteria:

  • Prehospital intubation; intubation performed solely for elective anesthesia/procedural sedation outside emergency indications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Adult patients in ED require emergent tracheal intubation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of major adverse peri-intubation events within 30 minutes after the start of intubation
Time Frame: Periprocedural, through 30 minutes after the start of intubation
severe hypoxemia, severe hypotension/cardiovascular instability, or cardiac arrest.
Periprocedural, through 30 minutes after the start of intubation

Secondary Outcome Measures

Outcome Measure
Time Frame
First-pass success
Time Frame: Periprocedural
Periprocedural
In-hospital mortality
Time Frame: From intubation to hospital discharge, assessed up to 90 days
From intubation to hospital discharge, assessed up to 90 days

Other Outcome Measures

Outcome Measure
Time Frame
Pre-intubation severe metabolic acidosis
Time Frame: Within 2 hours before the start of intubation
Within 2 hours before the start of intubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Chang Gung Memorial Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

July 1, 2029

Study Completion (Estimated)

December 1, 2029

Study Registration Dates

First Submitted

April 27, 2026

First Submitted That Met QC Criteria

May 5, 2026

First Posted (Actual)

May 8, 2026

Study Record Updates

Last Update Posted (Actual)

May 8, 2026

Last Update Submitted That Met QC Criteria

May 5, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 202501836B0

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

De-identified data will be retained under institutional governance and are not currently planned for public individual participant data sharing.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Airway Management

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe